Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Neil Stuart Horowitz, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Lin LH, Maestá I, St Laurent JD, Hasselblatt KT, Horowitz NS, Goldstein DP, Quade BJ, Sun SY, Braga A, Fisher RA, Berkowitz RS, Elias KM. Distinct microRNA profiles for complete hydatidiform moles at risk for malignant progression. Am J Obstet Gynecol. 2020 Oct 05. PMID: 33031755.
    Citations:    
  2. Jareemit N, Horowitz NS, Goldstein DP, Berkowitz RS, Elias KM. Outcomes for relapsed versus resistant low risk gestational trophoblastic neoplasia following single-agent chemotherapy. Gynecol Oncol. 2020 Oct 03. PMID: 33023756.
    Citations:    
  3. Kanbergs AN, Manning-Geist BL, Pelletier A, Sullivan MW, Del Carmen MG, Horowitz NS, Growdon WB, Clark RM, Muto MG, Worley MJ. Neoadjuvant chemotherapy does not disproportionately influence post-operative complication rates or time to chemotherapy in obese patients with advanced-stage ovarian cancer. Gynecol Oncol. 2020 Sep 18. PMID: 32951891.
    Citations:    
  4. Lee EK, Xiong N, Cheng SC, Barry WT, Penson RT, Konstantinopoulos PA, Hoffman MA, Horowitz N, Dizon DS, Stover EH, Wright AA, Campos SM, Krasner C, Morrissey S, Whalen C, Quinn R, Matulonis UA, Liu JF. Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial. Gynecol Oncol. 2020 Oct; 159(1):72-78. PMID: 32771276.
    Citations:    
  5. Harvey RA, Elias KM, Lim A, Bercow A, Short D, Horowitz NS, Berkowitz RS, Agarwal R, Seckl MJ. Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study. Curr Probl Cancer. 2020 Aug 04; 100622. PMID: 32800689.
    Citations:    
  6. Bunnell ME, Donovan BM, Parrack PH, Muto MG, Horowitz NS, Leung SOA. Female adnexal tumor of probable Wolffian Origin - A report of two cases at one institution. Gynecol Oncol Rep. 2020 Aug; 33:100612. PMID: 32775590.
    Citations:    
  7. Ferraz L, Ramos CAB, Braga A, Velarde LGC, Elias KM, Horowitz NS, Lopes PF, Berkowitz RS. Association between antioxidant vitamins and oxidative stress among patients with a complete hydatidiform mole. Clinics (Sao Paulo). 2020; 75:e1724. PMID: 32638907.
    Citations:    
  8. Li S, Manning-Geist B, Gockley A, Ramos A, Sisodia RC, Del Carmen M, Growdon WB, Horowitz N, Berkowitz R, Worley M. Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer. Int J Gynecol Cancer. 2020 Jul; 30(7):1052-1057. PMID: 32487686.
    Citations:    
  9. Khawajkie Y, Mechtouf N, Nguyen NMP, Rahimi K, Breguet M, Arseneau J, Ronnett BM, Hoffner L, Lazure F, Arnaud M, Peers F, Tan L, Rafea BA, Aguinaga M, Horowitz NS, Ao A, Tan SL, Brown R, Buckett W, Surti U, Hovanes K, Sahoo T, Sauthier P, Slim R. Correction: Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes. Mod Pathol. 2020 06; 33(6):1237. PMID: 32051555.
    Citations:    
  10. Braga A, Elias KM, Elias KM, Horowitz NS, Berkowitz RS. How to optimize the management of gestational trophoblastic disease during the coronavirus disease era? Am J Obstet Gynecol. 2020 10; 223(4):604-605. PMID: 32474011.
    Citations:    
  11. Schink JC, Filiaci V, Huang HQ, Tidy J, Winter M, Carter J, Anderson N, Moxley K, Yabuno A, Taylor SE, Kushnir C, Horowitz N, Miller DS. An international randomized phase III trial of pulse actinomycin-D versus multi-day methotrexate for the treatment of low risk gestational trophoblastic neoplasia; NRG/GOG 275. Gynecol Oncol. 2020 Aug; 158(2):354-360. PMID: 32460997.
    Citations:    
  12. Jareemit N, Horowitz NS, Goldstein DP, Berkowitz RS, Elias KM. EMA vs EMACO in the treatment of gestational trophoblastic neoplasia. Gynecol Oncol. 2020 Jul; 158(1):99-104. PMID: 32404247.
    Citations:    
  13. Freitas F, Braga A, Viggiano M, Velarde LGC, Maesta I, Uberti E, Madi JM, Yela D, Fernandes K, Silveira E, Leal E, Sun SY, Dos Santos Esteves APV, Filho JR, Junior JA, Elias KM, Horowitz NS, Berkowitz RS. Gestational trophoblastic neoplasia lethality among Brazilian women: A retrospective national cohort study. Gynecol Oncol. 2020 Aug; 158(2):452-459. PMID: 32402634.
    Citations:    
  14. Maestá I, de Freitas Segalla Moreira M, Rezende-Filho J, Bianconi MI, Jankilevich G, Otero S, Correa Ramirez LA, Sun SY, Elias K, Horowitz N, Braga A, Berkowitz R. Outcomes in the management of high-risk gestational trophoblastic neoplasia in trophoblastic disease centers in South America. Int J Gynecol Cancer. 2020 Sep; 30(9):1366-1371. PMID: 32376739.
    Citations:    
  15. Horowitz NS, Berkowitz RS, Elias KM. Important insights for non-molar choriocarcinoma. BJOG. 2020 08; 127(9):1108. PMID: 32232902.
    Citations:    
  16. Gonzalez R, Gockley AA, Melamed A, Sugrue R, Clark RM, Del Carmen MG, Growdon W, Berkowitz RS, Horowitz NS, Worley MJ. Multivariable analysis of association of beta-blocker use and survival in advanced ovarian cancer. Gynecol Oncol. 2020 Jun; 157(3):700-705. PMID: 32222327.
    Citations:    
  17. Maestá I, Nitecki R, Desmarais CCF, Horowitz NS, Goldstein DP, Elias KM, Berkowitz RS. Effectiveness and toxicity of second-line actinomycin D in patients with methotrexate-resistant postmolar low-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2020 05; 157(2):372-378. PMID: 32037196.
    Citations:    
  18. Braga A, de Souza Hartung Araújo C, Mora PAR, Paulino E, de Melo AC, Velarde GC, Dos Santos Esteves APV, Junior JA, Filho JR, Elias KM, Horowitz NS, Berkowitz RS. Comparison of treatment for low-risk GTN with standard 8-day MTX/FA regimen versus modified MTX/FA regimen without chemotherapy on the weekend. Gynecol Oncol. 2020 03; 156(3):598-605. PMID: 31928806.
    Citations:    
  19. Horowitz NS, Berkowitz RS, Elias KM. Considering Changes in the Recommended Human Chorionic Gonadotropin Monitoring After Molar Evacuation. Obstet Gynecol. 2020 01; 135(1):9-11. PMID: 31809444.
    Citations:    
  20. Khawajkie Y, Mechtouf N, Nguyen NMP, Rahimi K, Breguet M, Arseneau J, Ronnett BM, Hoffner L, Lazure F, Arnaud M, Peers F, Tan L, Rafea BA, Aguinaga M, Horowitz NS, Ao A, Tan SL, Brown R, Buckett W, Surti U, Hovanes K, Sahoo T, Sauthier P, Slim R. Comprehensive analysis of 204 sporadic hydatidiform moles: revisiting risk factors and their correlations with the molar genotypes. Mod Pathol. 2020 05; 33(5):880-892. PMID: 31857680.
    Citations:    
  21. Myers AP, Konstantinopoulos PA, Barry WT, Luo W, Broaddus RR, Makker V, Drapkin R, Liu J, Doyle A, Horowitz NS, Meric-Bernstam F, Birrer M, Aghajanian C, Coleman RL, Mills GB, Cantley LC, Matulonis UA, Westin SN. Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer. Int J Cancer. 2020 Jul 15; 147(2):413-422. PMID: 31714586.
    Citations:    
  22. Elias KM, Berkowitz RS, Horowitz NS. State-of-the-Art Workup and Initial Management of Newly Diagnosed Molar Pregnancy and Postmolar Gestational Trophoblastic Neoplasia. J Natl Compr Canc Netw. 2019 11 01; 17(11):1396-1401. PMID: 31693988.
    Citations:    
  23. Liu JF, Herold C, Gray KP, Penson RT, Horowitz N, Konstantinopoulos PA, Castro CM, Hill SJ, Curtis J, Luo W, Matulonis UA, Cannistra SA, Dizon DS. Assessment of Combined Nivolumab and Bevacizumab in Relapsed Ovarian Cancer: A Phase 2 Clinical Trial. JAMA Oncol. 2019 Oct 10. PMID: 31600397.
    Citations:    
  24. Elias KM, Berkowitz RS, Horowitz NS. Continued hCG surveillance following chemotherapy for gestational trophoblastic neoplasia: When is enough enough? Gynecol Oncol. 2019 10; 155(1):1-2. PMID: 31601360.
    Citations:    
  25. Lee EK, Tan-Wasielewski Z, Matulonis UA, Birrer MJ, Wright AA, Horowitz N, Konstantinopoulos PA, Curtis J, Liu JF. Results of an abbreviated Phase Ib study of the HDAC6 inhibitor ricolinostat and paclitaxel in recurrent ovarian, fallopian tube, or primary peritoneal cancer. Gynecol Oncol Rep. 2019 Aug; 29:118-122. PMID: 31467965.
    Citations:    
  26. Manning-Geist BL, Hicks-Courant K, Gockley AA, Clark RM, Del Carmen MG, Growdon WB, Horowitz NS, Berkowitz RS, Muto MG, Worley MJ. A novel classification of residual disease after interval debulking surgery for advanced-stage ovarian cancer to better distinguish oncologic outcome. Am J Obstet Gynecol. 2019 10; 221(4):326.e1-326.e7. PMID: 31082382.
    Citations:    
  27. Ditzel HM, Strickland KC, Meserve EE, Stover E, Konstantinopoulos PA, Matulonis UA, Muto MG, Liu JF, Feltmate C, Horowitz N, Berkowitz RS, Gupta M, Hecht JL, Lin DI, Jochumsen KM, Welch WR, Hirsch MS, Quade BJ, Lee KR, Crum CP, Mutter GL, Nucci MR, Howitt BE. Assessment of a Chemotherapy Response Score (CRS) System for Tubo-Ovarian High-Grade Serous Carcinoma (HGSC). Int J Gynecol Pathol. 2019 May; 38(3):230-240. PMID: 29750700.
    Citations:    Fields:    
  28. Veneris JT, Lee EK, Goebel EA, Nucci MR, Lindeman N, Horowitz NS, Lee L, Raut CP, Crotzer D, Matulonis U, Konstantinopoulos PA, Campos S. Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer. Gynecol Oncol. 2019 06; 153(3):471-478. PMID: 30935717.
    Citations:    
  29. Mora PAR, Sun SY, Velarde GC, Filho JR, Uberti EH, Dos Santos Esteves APV, Elias KM, Horowitz NS, Braga A, Berkowitz RS. Can carboplatin or etoposide replace actinomycin-d for second-line treatment of methotrexate resistant low-risk gestational trophoblastic neoplasia? Gynecol Oncol. 2019 05; 153(2):277-285. PMID: 30857648.
    Citations:    
  30. Gockley AA, Fiascone S, Hicks Courant K, Pepin K, Del Carmen M, Clark RM, Goldberg J, Horowitz N, Berkowitz R, Worley M. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma. Int J Gynecol Cancer. 2019 03; 29(3):585-592. PMID: 30833444.
    Citations:    
  31. Alimena S, Fiascone S, Krasner C, King M, Horowitz N. A tumor board report of an 83-year-old woman with stage IB grade 3 endometrioid endometrial adenocarcinoma. Curr Probl Cancer. 2019 10; 43(5):443-449. PMID: 30770127.
    Citations:    
  32. Puechl AM, Edwards J, Suri A, Nakayama J, Bean S, Gehrig P, Saks E, Duska L, Broadwater G, Ehrisman J, Horowitz N, Secord AA. The association between progesterone receptor expression and survival in women with adult granulosa cell tumors. Gynecol Oncol. 2019 04; 153(1):74-79. PMID: 30661765.
    Citations:    Fields:    
  33. Manning-Geist BL, Alimena S, Del Carmen MG, Goodman A, Clark RM, Growdon WB, Horowitz NS, Berkowitz RS, Muto MG, Worley MJ. Infection, thrombosis, and oncologic outcome after interval debulking surgery: Does perioperative blood transfusion matter? Gynecol Oncol. 2019 04; 153(1):63-67. PMID: 30635213.
    Citations:    Fields:    
  34. Soong TR, Howitt BE, Horowitz N, Nucci MR, Crum CP. The fallopian tube, "precursor escape" and narrowing the knowledge gap to the origins of high-grade serous carcinoma. Gynecol Oncol. 2019 02; 152(2):426-433. PMID: 30503267.
    Citations:    Fields:    
  35. Soong TR, Howitt BE, Miron A, Horowitz NS, Campbell F, Feltmate CM, Muto MG, Berkowitz RS, Nucci MR, Xian W, Crum CP. Evidence for lineage continuity between early serous proliferations (ESPs) in the Fallopian tube and disseminated high-grade serous carcinomas. J Pathol. 2018 11; 246(3):344-351. PMID: 30043522.
    Citations:    Fields:    
  36. Victoria Diniz M, Sun SY, Barsottini C, Viggiano M, Signorini Filho RC, Sanches Ozane Pimenta B, Elias KM, Horowitz NS, Braga A, Berkowitz RS. Experience With the Use of an Online Community on Facebook for Brazilian Patients With Gestational Trophoblastic Disease: Netnography Study. J Med Internet Res. 2018 09 24; 20(9):e10897. PMID: 30249575.
    Citations:    Fields:    
  37. Hill SJ, Decker B, Roberts EA, Horowitz NS, Muto MG, Worley MJ, Feltmate CM, Nucci MR, Swisher EM, Nguyen H, Yang C, Morizane R, Kochupurakkal BS, Do KT, Konstantinopoulos PA, Liu JF, Bonventre JV, Matulonis UA, Shapiro GI, Berkowitz RS, Crum CP, D'Andrea AD. Prediction of DNA Repair Inhibitor Response in Short-Term Patient-Derived Ovarian Cancer Organoids. Cancer Discov. 2018 11; 8(11):1404-1421. PMID: 30213835.
    Citations:    Fields:    
  38. Padrón L, Rezende-Filho J, Amim-Junior J, Sun SY, Cortés-Charry R, Maestá I, Elias KM, Horowitz NS, Braga A, Berkowitz RS. In Reply. Obstet Gynecol. 2018 07; 132(1):218. PMID: 29939922.
    Citations:    Fields:    
  39. Manning-Geist BL, Hicks-Courant K, Gockley AA, Clark RM, Del Carmen MG, Growdon WB, Horowitz NS, Berkowitz RS, Muto MG, Worley MJ. Moving beyond "complete surgical resection" and "optimal": Is low-volume residual disease another option for primary debulking surgery? Gynecol Oncol. 2018 08; 150(2):233-238. PMID: 29933927.
    Citations:    Fields:    Translation:Humans
  40. Davis M, Strickland K, Easter SR, Worley M, Feltmate C, Muto M, Horowitz N, Berkowitz R, Feldman S. The impact of health insurance status on the stage of cervical cancer diagnosis at a tertiary care center in Massachusetts. Gynecol Oncol. 2018 07; 150(1):67-72. PMID: 29751992.
    Citations:    Fields:    Translation:Humans
  41. Nitecki R, Berkowitz RS, Elias KM, Goldstein DP, Horowitz NS. Gestational Trophoblastic Disease Electronic Consults: What Do Patients and Physicians Want to Know? Int J Gynecol Cancer. 2018 05; 28(4):824-828. PMID: 29324544.
    Citations: 1     Fields:    
  42. Padrón L, Rezende Filho J, Amim Junior J, Sun SY, Charry RC, Maestá I, Elias KM, Horowitz N, Braga A, Berkowitz RS. Manual Compared With Electric Vacuum Aspiration for Treatment of Molar Pregnancy. Obstet Gynecol. 2018 04; 131(4):652-659. PMID: 29528932.
    Citations:    Fields:    
  43. Nitecki R, Davis M, Watkins JC, Wu YE, Vitonis AF, Muto MG, Berkowitz RS, Horowitz NS, Feltmate CM. Extramammary Paget Disease of the Vulva: A Case Series Examining Treatment, Recurrence, and Malignant Transformation. Int J Gynecol Cancer. 2018 03; 28(3):632-638. PMID: 29324542.
    Citations: 1     Fields:    
  44. Markt SC, Tang T, Cronin AM, Katz IT, Howitt BE, Horowitz NS, Lee LJ, Wright AA. Insurance status and cancer treatment mediate the association between race/ethnicity and cervical cancer survival. PLoS One. 2018; 13(2):e0193047. PMID: 29447263.
    Citations:    Fields:    Translation:Humans
  45. Braga A, Campos V, Filho JR, Lin LH, Sun SY, de Souza CB, da Silva RCAF, Leal EAS, Silveira E, Maestá I, Madi JM, Uberti EH, Viggiano M, Elias KM, Horowitz N, Berkowitz RS. Is chemotherapy always necessary for patients with nonmetastatic gestational trophoblastic neoplasia with histopathological diagnosis of choriocarcinoma? Gynecol Oncol. 2018 02; 148(2):239-246. PMID: 29248195.
    Citations:    Fields:    Translation:Humans
  46. Worley MJ, Elias KM, Horowitz NS, Quade BJ, Berkowitz RS. Durable remission for a woman with refractory choriocarcinoma treated with anti-endoglin monoclonal antibody and bevacizumab: A case from the New England Trophoblastic Disease Center, Brigham and Women's Hospital and Dana-Farber Cancer Institute. Gynecol Oncol. 2018 01; 148(1):5-11. PMID: 29217138.
    Citations:    Fields:    Translation:Humans
  47. Hamilton CA, Miller A, Casablanca Y, Horowitz NS, Rungruang B, Krivak TC, Richard SD, Rodriguez N, Birrer MJ, Backes FJ, Geller MA, Quinn M, Goodheart MJ, Mutch DG, Kavanagh JJ, Maxwell GL, Bookman MA. Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study. Gynecol Oncol. 2018 02; 148(2):275-280. PMID: 29195926.
    Citations: 1     Fields:    Translation:Humans
  48. Horowitz NS, Larry Maxwell G, Miller A, Hamilton CA, Rungruang B, Rodriguez N, Richard SD, Krivak TC, Fowler JM, Mutch DG, Van Le L, Lee RB, Argenta P, Bender D, Tewari KS, Gershenson D, Java JJ, Bookman MA. Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study. Gynecol Oncol. 2018 01; 148(1):49-55. PMID: 29174555.
    Citations:    Fields:    Translation:Humans
  49. Haggerty AF, Hagemann A, Barnett M, Thornquist M, Neuhouser ML, Horowitz N, Colditz GA, Sarwer DB, Ko EM, Allison KC. A Randomized, Controlled, Multicenter Study of Technology-Based Weight Loss Interventions among Endometrial Cancer Survivors. Obesity (Silver Spring). 2017 11; 25 Suppl 2:S102-S108. PMID: 29086522.
    Citations:    Fields:    Translation:Humans
  50. Maestá I, Nitecki R, Horowitz NS, Goldstein DP, de Freitas Segalla Moreira M, Elias KM, Berkowitz RS. Effectiveness and toxicity of first-line methotrexate chemotherapy in low-risk postmolar gestational trophoblastic neoplasia: The New England Trophoblastic Disease Center experience. Gynecol Oncol. 2018 01; 148(1):161-167. PMID: 29092742.
    Citations:    Fields:    Translation:Humans
  51. Pepin K, Bregar A, Davis M, Melamed A, Hinchcliff E, Gockley A, Horowitz N, Del Carmen MG. Intensive care admissions among ovarian cancer patients treated with primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery. Gynecol Oncol. 2017 12; 147(3):612-616. PMID: 28988028.
    Citations: 1     Fields:    Translation:Humans
  52. Meserve EEK, Mirkovic J, Conner JR, Yang E, Muto MG, Horowitz N, Strickland KC, Howitt BE, Crum CP. Frequency of "incidental" serous tubal intraepithelial carcinoma (STIC) in women without a history of or genetic risk factor for high-grade serous carcinoma: A six-year study. Gynecol Oncol. 2017 07; 146(1):69-73. PMID: 28479065.
    Citations: 1     Fields:    Translation:Humans
  53. Watkins JC, Yang EJ, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS, Syngal S, Yurgelun MB, Chittenden A, Hornick JL, Crum CP, Sholl LM, Howitt BE. Universal Screening for Mismatch-Repair Deficiency in Endometrial Cancers to Identify Patients With Lynch Syndrome and Lynch-like Syndrome. Int J Gynecol Pathol. 2017 Mar; 36(2):115-127. PMID: 27556954.
    Citations: 5     Fields:    Translation:HumansCells
  54. Lin LH, Maestá I, Braga A, Sun SY, Fushida K, Francisco RPV, Elias KM, Horowitz N, Goldstein DP, Berkowitz RS. Multiple pregnancies with complete mole and coexisting normal fetus in North and South America: A retrospective multicenter cohort and literature review. Gynecol Oncol. 2017 Apr; 145(1):88-95. PMID: 28132722.
    Citations: 2     Fields:    Translation:Humans
  55. Rungruang BJ, Miller A, Krivak TC, Horowitz NS, Rodriguez N, Hamilton CA, Backes FJ, Carson LF, Friedlander M, Mutch DG, Goodheart MJ, Tewari KS, Wenham RM, Bookman MA, Maxwell GL, Richard SD. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study. Cancer. 2017 May 15; 123(6):985-993. PMID: 27864921.
    Citations:    Fields:    Translation:Humans
  56. Watkins JC, Howitt BE, Horowitz NS, Ritterhouse LL, Dong F, MacConaill LE, Garcia E, Lindeman NI, Lee LJ, Berkowitz RS, Nucci MR, Crum CP. Differentiated exophytic vulvar intraepithelial lesions are genetically distinct from keratinizing squamous cell carcinomas and contain mutations in PIK3CA. Mod Pathol. 2017 03; 30(3):448-458. PMID: 27834349.
    Citations: 1     Fields:    Translation:Humans
  57. Dorney KM, Growdon WB, Clemmer J, Rauh-Hain JA, Hall TR, Diver E, Boruta D, Del Carmen MG, Goodman A, Schorge JO, Horowitz N, Clark RM. Patient, treatment and discharge factors associated with hospital readmission within 30days after surgery for vulvar cancer. Gynecol Oncol. 2017 Jan; 144(1):136-139. PMID: 27836203.
    Citations:    Fields:    Translation:Humans
  58. Bigelow CA, Horowitz NS, Goodman A, Growdon WB, Del Carmen M, Kaimal AJ. Management and outcome of cervical cancer diagnosed in pregnancy. Am J Obstet Gynecol. 2017 03; 216(3):276.e1-276.e6. PMID: 27810552.
    Citations: 1     Fields:    Translation:Humans
  59. Horowitz NS, Goldstein DP, Berkowitz RS. Placental site trophoblastic tumors and epithelioid trophoblastic tumors: Biology, natural history, and treatment modalities. Gynecol Oncol. 2017 Jan; 144(1):208-214. PMID: 27789086.
    Citations: 5     Fields:    Translation:Humans
  60. Melamed A, Gockley AA, Joseph NT, Sun SY, Clapp MA, Goldstein DP, Berkowitz RS, Horowitz NS. Effect of race/ethnicity on risk of complete and partial molar pregnancy after adjustment for age. Gynecol Oncol. 2016 10; 143(1):73-76. PMID: 27486130.
    Citations: 2     Fields:    Translation:Humans
  61. Davis M, Aviki E, Rauh-Hain JA, Worley M, Berkowitz R, Schorge J, Muto M, Clark Sisodia R, Horowitz N, Del Carmen M. Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer. Int J Gynecol Cancer. 2016 07; 26(6):1033-40. PMID: 27206282.
    Citations: 1     Fields:    Translation:Humans
  62. Lee LJ, Howitt B, Catalano P, Tanaka C, Murphy R, Cimbak N, DeMaria R, Bu P, Crum C, Horowitz N, Matulonis U, Viswanathan AN. Prognostic importance of human papillomavirus (HPV) and p16 positivity in squamous cell carcinoma of the vulva treated with radiotherapy. Gynecol Oncol. 2016 08; 142(2):293-8. PMID: 27210818.
    Citations: 5     Fields:    Translation:HumansCells
  63. Sherman ME, Drapkin RI, Horowitz NS, Crum CP, Friedman S, Kwon JS, Levine DA, Shih IeM, Shoupe D, Swisher EM, Walker J, Trabert B, Greene MH, Samimi G, Temkin SM, Minasian LM. Rationale for Developing a Specimen Bank to Study the Pathogenesis of High-Grade Serous Carcinoma: A Review of the Evidence. Cancer Prev Res (Phila). 2016 Sep; 9(9):713-20. PMID: 27221539.
    Citations: 2     Fields:    Translation:Humans
  64. Diver EJ, Horowitz NS, Goldstein DP, Bernstein M, Berkowitz RS, Growdon WB. Timing of Referral to the New England Trophoblastic Disease Center: Does Referral with Molar Pregnancy Versus Postmolar Gestational Trophoblastic Neoplasia Affect Outcomes? J Reprod Med. 2016 May-Jun; 61(5-6):187-91. PMID: 27424356.
    Citations:    Fields:    Translation:Humans
  65. Sun SY, Goldstein DP, Bernstein MR, Horowitz NS, Mattar R, Maestá I, Braga A, Berkowitz RS. Maternal Near Miss According to World Health Organization Classification Among Women with a Hydatidiform Mole: Experience at the New England Trophoblastic Disease Center, 1994-2013. J Reprod Med. 2016 May-Jun; 61(5-6):210-4. PMID: 27424360.
    Citations: 3     Fields:    Translation:Humans
  66. Berkowitz RS, Horowitz NS, Elias K, Goldstein DP. Gestational Trophoblastic Disease: Presentations from the XVIIIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2016 May-Jun; 61(5-6):185-6. PMID: 27424355.
    Citations:    Fields:    
  67. Gockley AA, Joseph NT, Melamed A, Sun SY, Goodwin B, Bernstein M, Goldstein DP, Berkowitz RS, Horowitz NS. Effect of race/ethnicity on clinical presentation and risk of gestational trophoblastic neoplasia in patients with complete and partial molar pregnancy at a tertiary care referral center. Am J Obstet Gynecol. 2016 09; 215(3):334.e1-6. PMID: 27130239.
    Citations: 2     Fields:    Translation:Humans
  68. Howitt BE, Sun HH, Roemer MG, Kelley A, Chapuy B, Aviki E, Pak C, Connelly C, Gjini E, Shi Y, Lee L, Viswanathan A, Horowitz N, Neuberg D, Crum CP, Lindeman NL, Kuo F, Ligon AH, Freeman GJ, Hodi FS, Shipp MA, Rodig SJ. Genetic Basis for PD-L1 Expression in Squamous Cell Carcinomas of the Cervix and Vulva. JAMA Oncol. 2016 Apr; 2(4):518-22. PMID: 26913631.
    Citations: 19     Fields:    Translation:Humans
  69. Sun SY, Melamed A, Joseph NT, Gockley AA, Goldstein DP, Bernstein MR, Horowitz NS, Berkowitz RS. Clinical Presentation of Complete Hydatidiform Mole and Partial Hydatidiform Mole at a Regional Trophoblastic Disease Center in the United States Over the Past 2 Decades. Int J Gynecol Cancer. 2016 Feb; 26(2):367-70. PMID: 26588240.
    Citations: 2     Fields:    Translation:Humans
  70. Gockley AA, Melamed A, Joseph NT, Clapp M, Sun SY, Goldstein DP, Horowitz NS, Berkowitz RS. The effect of adolescence and advanced maternal age on the incidence of complete and partial molar pregnancy. Gynecol Oncol. 2016 Mar; 140(3):470-3. PMID: 26777992.
    Citations: 2     Fields:    Translation:Humans
  71. Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1606-7. PMID: 25631066.
    Citations:    Fields:    
  72. Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Erratum to: Anesthetic Selection and Disease-Free Survival Following Optimal Primary Cytoreductive Surgery for Stage III Epithelial Ovarian Cancer. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S1611. PMID: 25821001.
    Citations:    Fields:    
  73. Goldstein DP, Berkowitz RS, Horowitz NS. Optimal management of low-risk gestational trophoblastic neoplasia. Expert Rev Anticancer Ther. 2015; 15(11):1293-304. PMID: 26517533.
    Citations: 2     Fields:    Translation:Humans
  74. Horowitz N, Miller A, Rungruang B, Richard S, Rodriguez N, Bookman MA, Hamilton C, Krivak T, Maxwell GL. Reply to G.D. Aletti et al. J Clin Oncol. 2015 Oct 20; 33(30):3521-2. PMID: 26304879.
    Citations: 1     Fields:    Translation:Humans
  75. Mahdi H, Gockley A, Esselen K, Marquard J, Nutter B, Yang B, Hinchcliff E, Horowitz N, Rose PG. Outcome of neoadjuvant chemotherapy in BRCA1/2 mutation positive women with advanced-stage Müllerian cancer. Gynecol Oncol. 2015 Dec; 139(3):407-12. PMID: 26210778.
    Citations: 2     Fields:    Translation:Humans
  76. Matulonis U, Berlin S, Lee H, Whalen C, Obermayer E, Penson R, Liu J, Campos S, Krasner C, Horowitz N. Phase I study of combination of vorinostat, carboplatin, and gemcitabine in women with recurrent, platinum-sensitive epithelial ovarian, fallopian tube, or peritoneal cancer. Cancer Chemother Pharmacol. 2015 Aug; 76(2):417-23. PMID: 26119093.
    Citations: 8     Fields:    Translation:HumansCTClinical Trials
  77. Sun SY, Melamed A, Goldstein DP, Bernstein MR, Horowitz NS, Moron AF, Maestá I, Braga A, Berkowitz RS. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Gynecol Oncol. 2015 Jul; 138(1):46-9. PMID: 25969351.
    Citations: 5     Fields:    Translation:Humans
  78. Melamed A, Katz Eriksen JL, Hinchcliff EM, Worley MJ, Berkowitz RS, Horowitz NS, Muto MG, Urman RD, Feltmate CM. Same-Day Discharge After Laparoscopic Hysterectomy for Endometrial Cancer. Ann Surg Oncol. 2016 Jan; 23(1):178-85. PMID: 25956576.
    Citations: 1     Fields:    Translation:Humans
  79. Maestá I, Horowitz NS, Goldstein DP, Bernstein MR, Ramírez LA, Moulder J, Berkowitz RS. Response to chemotherapy in overweight/obese patients with low-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer. 2015 May; 25(4):734-40. PMID: 25675037.
    Citations:    Fields:    Translation:Humans
  80. Maestá I, Berkowitz RS, Goldstein DP, Bernstein MR, Ramírez LA, Horowitz NS. Relationship between race and clinical characteristics, extent of disease, and response to chemotherapy in patients with low-risk gestational trophoblastic neoplasia. Gynecol Oncol. 2015 Jul; 138(1):50-4. PMID: 25933681.
    Citations: 2     Fields:    Translation:Humans
  81. Horowitz NS, Wright AA. Impact of obesity on chemotherapy management and outcomes in women with gynecologic malignancies. Gynecol Oncol. 2015 Jul; 138(1):201-6. PMID: 25870918.
    Citations: 7     Fields:    Translation:Humans
  82. Viswanathan AN, Moughan J, Miller BE, Xiao Y, Jhingran A, Portelance L, Bosch WR, Matulonis UA, Horowitz NS, Mannel RS, Souhami L, Erickson BA, Winter KA, Small W, Gaffney DK. NRG Oncology/RTOG 0921: A phase 2 study of postoperative intensity-modulated radiotherapy with concurrent cisplatin and bevacizumab followed by carboplatin and paclitaxel for patients with endometrial cancer. Cancer. 2015 Jul 01; 121(13):2156-63. PMID: 25847373.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  83. Davis MR, Howitt BE, Quade BJ, Crum CP, Horowitz NS, Goldstein DP, Berkowitz RS. Epithelioid trophoblastic tumor: A single institution case series at the New England Trophoblastic Disease Center. Gynecol Oncol. 2015 Jun; 137(3):456-61. PMID: 25773203.
    Citations: 3     Fields:    Translation:Humans
  84. Howitt BE, Hanamornroongruang S, Lin DI, Conner JE, Schulte S, Horowitz N, Crum CP, Meserve EE. Evidence for a dualistic model of high-grade serous carcinoma: BRCA mutation status, histology, and tubal intraepithelial carcinoma. Am J Surg Pathol. 2015 Mar; 39(3):287-93. PMID: 25581732.
    Citations: 17     Fields:    Translation:Humans
  85. Montero J, Sarosiek KA, DeAngelo JD, Maertens O, Ryan J, Ercan D, Piao H, Horowitz NS, Berkowitz RS, Matulonis U, Jänne PA, Amrein PC, Cichowski K, Drapkin R, Letai A. Drug-induced death signaling strategy rapidly predicts cancer response to chemotherapy. Cell. 2015 Feb 26; 160(5):977-989. PMID: 25723171.
    Citations: 64     Fields:    Translation:HumansCells
  86. Horowitz NS, Miller A, Rungruang B, Richard SD, Rodriguez N, Bookman MA, Hamilton CA, Krivak TC, Maxwell GL. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol. 2015 Mar 10; 33(8):937-43. PMID: 25667285.
    Citations: 28     Fields:    Translation:Humans
  87. Aviki EM, Esselen KM, Barcia SM, Nucci MR, Horowitz NS, Feltmate CM, Berkowitz RS, Orgill DG, Viswanathan AN, Muto MG. Does plastic surgical consultation improve the outcome of patients undergoing radical vulvectomy for squamous cell carcinoma of the vulva? Gynecol Oncol. 2015 Apr; 137(1):60-5. PMID: 25667974.
    Citations: 1     Fields:    Translation:Humans
  88. Rauh-Hain JA, Foley OW, Winograd D, Andrade C, Clark RM, Vargas RJ, Hinchcliff EM, Esselen KM, Horowitz NS, del Carmen MG. Clinical characteristics and outcomes of patients with stage I epithelial ovarian cancer compared with fallopian tube cancer. Am J Obstet Gynecol. 2015 May; 212(5):600.e1-8. PMID: 25514761.
    Citations: 2     Fields:    Translation:Humans
  89. Owusu-Darko S, Rauh-Hain JA, Horowitz NS, Goodman A, Schorge JO, Del Carmen MG. Comparison of outcomes in patients with early-stage mucinous endometrial cancer and those with endometrioid endometrial cancer, with and without adjuvant therapy. J Reprod Med. 2014 Nov-Dec; 59(11-12):527-33. PMID: 25552123.
    Citations:    Fields:    Translation:Humans
  90. Rauh-Hain JA, Goodman A, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Endometrial stromal sarcoma: a clinicopathologic study of 29 patients. J Reprod Med. 2014 Nov-Dec; 59(11-12):547-52. PMID: 25552126.
    Citations: 1     Fields:    Translation:Humans
  91. Zaino RJ, Brady WE, Todd W, Leslie K, Fischer EG, Horowitz NS, Mannel RS, Walker JL, Ivanovic M, Duska LR. Histologic effects of medroxyprogesterone acetate on endometrioid endometrial adenocarcinoma: a Gynecologic Oncology Group study. Int J Gynecol Pathol. 2014 Nov; 33(6):543-53. PMID: 25272292.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  92. Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol. 2015 Apr; 22(4):1341-8. PMID: 25287437.
    Citations: 6     Fields:    Translation:Humans
  93. Worley MJ, Davis M, Berhie SH, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS, Campos SM. Mucinous differentiation does not impact stage or risk of recurrence among patients with grade 1, endometrioid type, endometrial carcinoma. Gynecol Oncol. 2014 Oct; 135(1):54-7. PMID: 25088333.
    Citations:    Fields:    Translation:Humans
  94. Viswanathan AN, Lee LJ, Eswara JR, Horowitz NS, Konstantinopoulos PA, Mirabeau-Beale KL, Rose BS, von Keudell AG, Wo JY. Complications of pelvic radiation in patients treated for gynecologic malignancies. Cancer. 2014 Dec 15; 120(24):3870-83. PMID: 25056522.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  95. Berkowitz RS, Horowitz NS, Goldstein DP. Gestational trophoblastic disease: presentations from the XVIIth World Congress on Gestational Trophoblastic Diseases. J Reprod Med. 2014 May-Jun; 59(5-6):187. PMID: 24937954.
    Citations:    Fields:    Translation:Humans
  96. Worley MJ, Guseh SH, Rauh-Hain JA, Esselen KM, Muto MG, Feltmate CM, Berkowitz RS, Del Carmen MG, Schorge JO, Horowitz NS. What is the optimal treatment for obese patients with advanced ovarian carcinoma? Am J Obstet Gynecol. 2014 Sep; 211(3):231.e1-9. PMID: 24704062.
    Citations: 5     Fields:    Translation:Humans
  97. Vargas R, Rauh-Hain JA, Clemmer J, Clark RM, Goodman A, Growdon WB, Schorge JO, Del Carmen MG, Horowitz NS, Boruta DM. Tumor size, depth of invasion, and histologic grade as prognostic factors of lymph node involvement in endometrial cancer: a SEER analysis. Gynecol Oncol. 2014 May; 133(2):216-20. PMID: 24548726.
    Citations: 12     Fields:    Translation:Humans
  98. Davis M, Rauh-Hain JA, Andrade C, Boruta DM, Schorge JO, Horowitz NS, May T, del Carmen MG. Comparison of clinical outcomes of patients with clear cell and endometrioid ovarian cancer associated with endometriosis to papillary serous carcinoma of the ovary. Gynecol Oncol. 2014 Mar; 132(3):760-6. PMID: 24440832.
    Citations: 12     Fields:    Translation:Humans
  99. Conner JR, Meserve E, Pizer E, Garber J, Roh M, Urban N, Drescher C, Quade BJ, Muto M, Howitt BE, Pearlman MD, Berkowitz RS, Horowitz N, Crum CP, Feltmate C. Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations. Gynecol Oncol. 2014 Feb; 132(2):280-6. PMID: 24333842.
    Citations: 14     Fields:    Translation:Humans
  100. Viswanathan AN, Lee H, Berkowitz R, Berlin S, Campos S, Feltmate C, Horowitz N, Muto M, Sadow CA, Matulonis U. A prospective feasibility study of radiation and concurrent bevacizumab for recurrent endometrial cancer. Gynecol Oncol. 2014 Jan; 132(1):55-60. PMID: 24201015.
    Citations: 6     Fields:    Translation:Humans
  101. Mitchell DG, Javitt MC, Glanc P, Bennett GL, Brown DL, Dubinsky T, Harisinghani MG, Harris RD, Horowitz NS, Pandharipande PV, Pannu HK, Podrasky AE, Royal HD, Shipp TD, Siegel CL, Simpson L, Wong-You-Cheong JJ, Zelop CM. ACR appropriateness criteria staging and follow-up of ovarian cancer. J Am Coll Radiol. 2013 Nov; 10(11):822-7. PMID: 24183551.
    Citations: 6     Fields:    Translation:Humans
  102. Rauh-Hain JA, Guseh SH, Esselen KM, Growdon WB, Schorge JO, Horowitz NS, Krasner CN, del Carmen MG, Birrer MJ, Dizon DS. Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2013 Sep; 23(7):1219-25. PMID: 23975042.
    Citations:    Fields:    Translation:Humans
  103. Suri A, Carter EB, Horowitz N, Denslow S, Gehrig PA. Factors associated with an increased risk of recurrence in women with ovarian granulosa cell tumors. Gynecol Oncol. 2013 Nov; 131(2):321-4. PMID: 23994106.
    Citations: 3     Fields:    Translation:Humans
  104. Rauh-Hain JA, Shoni M, Schorge JO, Goodman A, Horowitz NS, del Carmen MG. Prognostic determinants in patients with uterine and ovarian carcinosarcoma. J Reprod Med. 2013 Jul-Aug; 58(7-8):297-304. PMID: 23947079.
    Citations: 2     Fields:    Translation:Humans
  105. Rodriguez N, Miller A, Richard SD, Rungruang B, Hamilton CA, Bookman MA, Maxwell GL, Horowitz NS, Krivak TC. Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182. Gynecol Oncol. 2013 Sep; 130(3):487-92. PMID: 23791702.
    Citations: 4     Fields:    Translation:Humans
  106. Maestá I, Growdon WB, Goldstein DP, Bernstein MR, Horowitz NS, Rudge MV, Berkowitz RS. Prognostic factors associated with time to hCG remission in patients with low-risk postmolar gestational trophoblastic neoplasia. Gynecol Oncol. 2013 Aug; 130(2):312-6. PMID: 23707672.
    Citations: 2     Fields:    Translation:Humans
  107. Worley MJ, Guseh SH, Rauh-Hain JA, Williams KA, Muto MG, Feltmate CM, Berkowitz RS, Horowitz NS. Does neoadjuvant chemotherapy decrease the risk of hospital readmission following debulking surgery? Gynecol Oncol. 2013 Apr; 129(1):69-73. PMID: 23375727.
    Citations: 4     Fields:    Translation:Humans
  108. Rauh-Hain JA, Nitschmann CC, Worley MJ, Bradford LS, Berkowitz RS, Schorge JO, Campos SM, del Carmen MG, Horowitz NS. Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. Gynecol Oncol. 2013 Apr; 129(1):63-8. PMID: 23337490.
    Citations: 9     Fields:    Translation:Humans
  109. Campos SM, Penson RT, Matulonis U, Horowitz NS, Whalen C, Pereira L, Tyburski K, Roche M, Szymonifka J, Berlin S. A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma. Gynecol Oncol. 2013 Feb; 128(2):215-20. PMID: 22885865.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  110. Quick CM, May T, Horowitz NS, Nucci MR. Low-grade, low-stage endometrioid endometrial adenocarcinoma: a clinicopathologic analysis of 324 cases focusing on frequency and pattern of myoinvasion. Int J Gynecol Pathol. 2012 Jul; 31(4):337-43. PMID: 22653347.
    Citations: 9     Fields:    Translation:Humans
  111. Horowitz NS, Olawaiye AB, Borger DR, Growdon WB, Krasner CN, Matulonis UA, Liu JF, Lee J, Brard L, Dizon DS. Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva. Gynecol Oncol. 2012 Oct; 127(1):141-6. PMID: 22750258.
    Citations: 6     Fields:    Translation:HumansCTClinical Trials
  112. Siegel CL, Andreotti RF, Cardenes HR, Brown DL, Gaffney DK, Horowitz NS, Javitt MC, Lee SI, Mitchell DG, Moore DH, Rao GG, Royal HD, Small W, Varia MA, Yashar CM. ACR Appropriateness Criteria® pretreatment planning of invasive cancer of the cervix. J Am Coll Radiol. 2012 Jun; 9(6):395-402. PMID: 22632665.
    Citations: 4     Fields:    Translation:Humans
  113. Esselen KM, Rodriguez N, Growdon W, Krasner C, Horowitz NS, Campos S. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy. Gynecol Oncol. 2012 Oct; 127(1):51-4. PMID: 22659193.
    Citations: 6     Fields:    Translation:Humans
  114. Shah NT, Barroilhet L, Berkowitz RS, Goldstein DP, Horowitz N. A cost analysis of first-line chemotherapy for low-risk gestational trophoblastic neoplasia. J Reprod Med. 2012 May-Jun; 57(5-6):211-8. PMID: 22696815.
    Citations: 1     Fields:    Translation:Humans
  115. Growdon WB, Rauh-Hain JJ, Cordon A, Garrett L, Schorge JO, Goodman A, Boruta DM, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage I uterine papillary serous carcinoma: a 15-year multi-institutional review. Int J Gynecol Cancer. 2012 Mar; 22(3):417-24. PMID: 22237383.
    Citations: 4     Fields:    Translation:Humans
  116. Rauh-Hain JA, Winograd D, Growdon WB, Schorge JO, Goodman AK, Boruta DM, Berkowitz RS, Horowitz NS, Del Carmen MG. Prognostic determinants in patients with uterine and ovarian clear carcinoma. Gynecol Oncol. 2012 May; 125(2):376-80. PMID: 22366593.
    Citations: 7     Fields:    Translation:Humans
  117. Rodriguez N, Rauh-Hain JA, Shoni M, Berkowitz RS, Muto MG, Feltmate C, Schorge JO, Del Carmen MG, Matulonis UA, Horowitz NS. Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. Gynecol Oncol. 2012 May; 125(2):362-6. PMID: 22333992.
    Citations: 10     Fields:    Translation:Humans
  118. Horowitz N, Matulonis UA. New biologic agents for the treatment of gynecologic cancers. Hematol Oncol Clin North Am. 2012 Feb; 26(1):133-56. PMID: 22244666.
    Citations:    Fields:    Translation:HumansCells
  119. Campos SM, Berlin S, Matulonis UA, Muto MG, Pereira L, Mosquera MM, Horowitz N. Young women diagnosed with early-stage ovarian cancer or borderline malignancy of the ovary: a focus on fertility and sexual function. J Psychosoc Oncol. 2012; 30(4):387-401. PMID: 22747104.
    Citations: 2     Fields:    Translation:Humans
  120. Horowitz NS. Management of adnexal masses in pregnancy. Clin Obstet Gynecol. 2011 Dec; 54(4):519-27. PMID: 22031242.
    Citations: 2     Fields:    Translation:Humans
  121. Rungruang B, Miller A, Richard SD, Hamilton CA, Rodriguez N, Bookman MA, Maxwell GL, Krivak TC, Horowitz NS. Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Jan; 124(1):53-8. PMID: 22032836.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  122. Rauh-Hain JA, Rodriguez N, Growdon WB, Goodman AK, Boruta DM, Horowitz NS, del Carmen MG, Schorge JO. Primary debulking surgery versus neoadjuvant chemotherapy in stage IV ovarian cancer. Ann Surg Oncol. 2012 Mar; 19(3):959-65. PMID: 21994038.
    Citations: 13     Fields:    Translation:Humans
  123. Killelea BK, Grube BJ, Philpotts L, Sowden M, Horowitz N, Lannin DR. Characteristics of multifocal and multicentric breast cancers detetected by preoperative MRI. J Clin Oncol. 2011 Sep 20; 29(27_suppl):67. PMID: 27958129.
    Citations:    
  124. Lannin DR, Grube BJ, Killelea BK, Horowitz N, Harris L. Surgical and oncologic outcomes in patients with breast cancer undergoing tattooing prior to neoadjuvant chemotherapy. J Clin Oncol. 2011 Sep 20; 29(27_suppl):100. PMID: 27958116.
    Citations:    
  125. Horowitz NS, Penson RT, Duda DG, di Tomaso E, Boucher Y, Ancukiewicz M, Cohen KS, Berlin S, Krasner CN, Moses MA, Jain RK. Safety, Efficacy, and Biomarker Exploration in a Phase II Study of Bevacizumab, Oxaliplatin, and Gemcitabine in Recurrent Müllerian Carcinoma. Clin Ovarian Cancer Other Gynecol Malig. 2011 Jun; 4(1):26-33. PMID: 21833345.
    Citations: 8     
  126. Lee JH, Dubinsky T, Andreotti RF, Cardenes HR, Dejesus Allison SO, Gaffney DK, Glanc P, Horowitz NS, Jhingran A, Lee SI, Puthawala AA, Royal HD, Scoutt LM, Small W, Varia MA, Zelop CM. ACR appropriateness Criteria® pretreatment evaluation and follow-up of endometrial cancer of the uterus. Ultrasound Q. 2011 Jun; 27(2):139-45. PMID: 21606818.
    Citations: 4     Fields:    Translation:Humans
  127. Esselen KM, Rodriguez N, Horowitz NS, Campos SM. Patterns of recurrence in advanced epithelial ovarian, fallopian tube, and peritoneal cancers treated with intraperitoneal chemotherapy. J Clin Oncol. 2011 May 20; 29(15_suppl):5072. PMID: 28023665.
    Citations:    
  128. Viswanathan AN, Szymonifka J, Tanaka C, Berlin ST, Campos SM, Horowitz NS, Lee J, Whalen C, Matulonis U. The use of bevacizumab and concurrent radiation for recurrent gynecologic cancers. J Clin Oncol. 2011 May 20; 29(15_suppl):5101. PMID: 28019903.
    Citations:    
  129. Rauh-Hain JA, Growdon WB, Rodriguez N, Goodman AK, Boruta DM, Schorge JO, Horowitz NS, del Carmen MG. Carcinosarcoma of the ovary: a case-control study. Gynecol Oncol. 2011 Jun 01; 121(3):477-81. PMID: 21420726.
    Citations: 13     Fields:    Translation:Humans
  130. Brown DL, Andreotti RF, Lee SI, Dejesus Allison SO, Bennett GL, Dubinsky T, Glanc P, Horrow MM, Lev-Toaff AS, Horowitz NS, Podrasky AE, Scoutt LM, Zelop CM. ACR appropriateness criteria© ovarian cancer screening. Ultrasound Q. 2010 Dec; 26(4):219-23. PMID: 21084936.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  131. Rauh-Hain JA, Growdon WB, Schorge JO, Goodman AK, Boruta DM, McCann C, Horowitz NS, del Carmen MG. Prognostic determinants in patients with stage IIIC and IV uterine papillary serous carcinoma. Gynecol Oncol. 2010 Nov; 119(2):299-304. PMID: 20691465.
    Citations: 6     Fields:    Translation:Humans
  132. Duska LR, Garrett L, Henretta M, Ferriss JS, Lee L, Horowitz N. When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial histologic subtypes. Gynecol Oncol. 2010 Mar; 116(3):374-7. PMID: 19922988.
    Citations: 22     Fields:    Translation:Humans
  133. Rauh-Hain JA, Costaaggini I, Olawaiye AB, Growdon WB, Horowitz NS, del Carmen MG. A comparison of outcome in patients with stage 1 clear cell and grade 3 endometrioid adenocarcinoma of the endometrium with and without adjuvant therapy. Eur J Gynaecol Oncol. 2010; 31(3):284-7. PMID: 21077469.
    Citations:    Fields:    Translation:Humans
  134. Rauh-Hain JA, del Carmen M, Horowitz NS, Alarcon IA, Ko E, Goodman AK, Olawaiye AB. Impact of bowel obstruction at the time of initial presentation in women with ovarian cancer. BJOG. 2010 Jan; 117(1):32-8. PMID: 20002368.
    Citations:    Fields:    Translation:Humans
  135. Penson RT, Dizon DS, Cannistra SA, Roche MR, Krasner CN, Berlin ST, Horowitz NS, Disilvestro PA, Matulonis UA, Lee H, King MA, Campos SM. Phase II study of carboplatin, paclitaxel, and bevacizumab with maintenance bevacizumab as first-line chemotherapy for advanced mullerian tumors. J Clin Oncol. 2010 Jan 01; 28(1):154-9. PMID: 19917843.
    Citations: 29     Fields:    Translation:HumansCTClinical Trials
  136. Matulonis UA, Berlin S, Ivy P, Tyburski K, Krasner C, Zarwan C, Berkenblit A, Campos S, Horowitz N, Cannistra SA, Lee H, Lee J, Roche M, Hill M, Whalen C, Sullivan L, Tran C, Humphreys BD, Penson RT. Cediranib, an oral inhibitor of vascular endothelial growth factor receptor kinases, is an active drug in recurrent epithelial ovarian, fallopian tube, and peritoneal cancer. J Clin Oncol. 2009 Nov 20; 27(33):5601-6. PMID: 19826113.
    Citations: 71     Fields:    Translation:HumansCTClinical Trials
  137. Boyce EA, Costaggini I, Vitonis A, Feltmate C, Muto M, Berkowitz R, Cramer D, Horowitz NS. The epidemiology of ovarian granulosa cell tumors: a case-control study. Gynecol Oncol. 2009 Nov; 115(2):221-5. PMID: 19664811.
    Citations: 3     Fields:    Translation:Humans
  138. Horowitz NS, Goldstein DP, Berkowitz RS. Management of gestational trophoblastic neoplasia. Semin Oncol. 2009 Apr; 36(2):181-9. PMID: 19332252.
    Citations: 1     Fields:    Translation:Humans
  139. Lee L, Garrett L, Lee H, Oliva E, Horowitz N, Duska LR. Association of clear cell carcinoma of the endometrium with a high rate of venous thromboembolism. J Reprod Med. 2009 Mar; 54(3):133-8. PMID: 19370896.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  140. Matulonis UA, Krag KJ, Krasner CN, Atkinson T, Horowitz NS, Lee H, Penson RT. Phase II prospective study of paclitaxel and carboplatin in older patients with newly diagnosed Müllerian tumors. Gynecol Oncol. 2009 Feb; 112(2):394-9. PMID: 19058838.
    Citations: 5     Fields:    Translation:HumansCTClinical Trials
  141. Matulonis UA, Horowitz NS, Campos SM, Lee H, Lee J, Krasner CN, Berlin S, Roche MR, Duska LR, Pereira L, Kendall D, Penson RT. Phase II study of carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer. J Clin Oncol. 2008 Dec 10; 26(35):5761-6. PMID: 19001330.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  142. Growdon WB, Boisvert SL, Akhavanfard S, Oliva E, Dias-Santagata DC, Kojiro S, Horowitz NS, Iafrate AJ, Borger DR, Rueda BR. Decreased survival in EGFR gene amplified vulvar carcinoma. Gynecol Oncol. 2008 Nov; 111(2):289-97. PMID: 18768215.
    Citations: 11     Fields:    Translation:HumansCells
  143. Nagymanyoki Z, Growdon WB, Sarno J, Callahan MJ, Parast MM, Fulop V, Mok SC, Horowitz N, Berkowitz RS. Vascularization and expression of angiogenic factors in partial and complete molar pregnancies. J Reprod Med. 2008 Aug; 53(8):589-94. PMID: 18773623.
    Citations:    Fields:    Translation:Humans
  144. Horowitz NS, Penson RT, Campos SM, Lee J, Kendall DL, Krasner CN, Berlin ST, Roche M, Duska LR, Matulonis UA. Combination carboplatin and pemetrexed for the treatment of platinum-sensitive recurrent ovarian cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):5523. PMID: 27950841.
    Citations:    
  145. Penson RT, Kornblith AB, Lee J, Roche M, Atkinson T, Gibson CD, Horowitz NS, Krag KJ, Krasner CN, Matulonis UA. Phase II study of carboplatin and paclitaxel in elderly women with newly diagnosed ovarian, peritoneal, or fallopian tube cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):5590. PMID: 27950420.
    Citations:    
  146. Duda DG, Cohen KS, Ancukiewicz M, di Tomaso E, Zhu AX, Penson RT, Horowitz NS, Batchelor TT, Willett CG, Jain RK. A comparative study of circulating endothelial cells (CECs) and circulating progenitor cells (CPCs) kinetics in four multidisciplinary phase II studies of antiangiogenic agents. J Clin Oncol. 2008 May 20; 26(15_suppl):3544. PMID: 27949773.
    Citations:    
  147. Sebastian S, Lee SI, Horowitz NS, Scott JA, Fischman AJ, Simeone JF, Fuller AF, Hahn PF. PET-CT vs. CT alone in ovarian cancer recurrence. Abdom Imaging. 2008 Jan-Feb; 33(1):112-8. PMID: 17404789.
    Citations: 13     Fields:    Translation:Humans
  148. Miller JC, Horowitz NS, Thrall JH, Lee SI. Evaluating adnexal lesions: which need follow-up? J Am Coll Radiol. 2007 Oct; 4(10):725-9. PMID: 17903760.
    Citations:    Fields:    Translation:Humans
  149. Horowitz NS, Hua J, Powell MA, Gibb RK, Mutch DG, Herzog TJ. Novel cytotoxic agents from an unexpected source: bile acids and ovarian tumor apoptosis. Gynecol Oncol. 2007 Nov; 107(2):344-9. PMID: 17720233.
    Citations: 5     Fields:    Translation:HumansCells
  150. Gius D, Funk MC, Chuang EY, Feng S, Huettner PC, Nguyen L, Bradbury CM, Mishra M, Gao S, Buttin BM, Cohn DE, Powell MA, Horowitz NS, Whitcomb BP, Rader JS. Profiling microdissected epithelium and stroma to model genomic signatures for cervical carcinogenesis accommodating for covariates. Cancer Res. 2007 Aug 01; 67(15):7113-23. PMID: 17671178.
    Citations: 31     Fields:    Translation:HumansCells
  151. Olawaiye A, Lee LM, Krasner C, Horowitz N. Treatment of squamous cell vulvar cancer with the anti-EGFR tyrosine kinase inhibitor Tarceva. Gynecol Oncol. 2007 Sep; 106(3):628-30. PMID: 17561233.
    Citations: 4     Fields:    Translation:Humans
  152. Hoffman KE, Horowitz NS, Russell AH. Healing of vulvo-vaginal radionecrosis following revascularization. Gynecol Oncol. 2007 Jul; 106(1):262-4. PMID: 17507081.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  153. del Carmen MG, Findley M, Muzikansky A, Roche M, Verrill CL, Horowitz N, Seiden MV. Demographic, risk factor, and knowledge differences between Latinas and non-Latinas referred to colposcopy. Gynecol Oncol. 2007 Jan; 104(1):70-6. PMID: 16949138.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  154. Vaidya AP, Horowitz NS, Oliva E, Halpern EF, Duska LR. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma. Gynecol Oncol. 2006 Nov; 103(2):684-7. PMID: 16797683.
    Citations: 10     Fields:    Translation:Humans
  155. Penson RT, Cannistra SA, Seiden MV, Krasner CN, Matulonis UA, Horowitz NS, Berlin S, Dizon DS, Lee H, Campos SM. Phase II study of carboplatin, paclitaxel and bevacizumab as first line chemotherapy and consolidation for advanced müllerian tumors. J Clin Oncol. 2006 Jun 20; 24(18_suppl):5020. PMID: 27952190.
    Citations:    
  156. Roche M, Matulonis U, Krasner C, Penson R, Horowitz N, Berkenblit A, Findley M, Lee J, Horick N, Seiden MV. Phase II trial of GM-CSF in women with asymptomatic müllerian cancer. J Clin Oncol. 2006 Jun 20; 24(18_suppl):5081. PMID: 27952385.
    Citations:    
  157. Gossner G, Coleman RL, Mutch DG, Horowitz NS, Rader JS, Gibb RK, Powell MA, Herzog TJ. CA-125 response in patients with recurrent ovarian or primary peritoneal cancer treated with pegylated liposomal doxorubicin or topotecan. Gynecol Oncol. 2006 Oct; 103(1):212-8. PMID: 16677696.
    Citations: 4     Fields:    Translation:Humans
  158. Krasner CN, Roche M, Horowitz NS, Supko JG, Lee SI, Oliva E. Case records of the Massachusetts General Hospital. Case 11-2006. A 54-year-old woman with a mass in the pelvis. N Engl J Med. 2006 Apr 13; 354(15):1615-25. PMID: 16611953.
    Citations: 2     Fields:    Translation:Humans
  159. Horowitz NS, Duska LR. Advances in the surgical management of ovarian cancer. J Reprod Med. 2005 Jun; 50(6):454-66. PMID: 16050570.
    Citations:    Fields:    Translation:Humans
  160. Horowitz NS, Dehdashti F, Herzog TJ, Rader JS, Powell MA, Gibb RK, Grigsby PW, Siegel BA, Mutch DG. Prospective evaluation of FDG-PET for detecting pelvic and para-aortic lymph node metastasis in uterine corpus cancer. Gynecol Oncol. 2004 Dec; 95(3):546-51. PMID: 15581961.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  161. Horowitz NS, Hua J, Gibb RK, Mutch DG, Herzog TJ. The role of topotecan for extending the platinum-free interval in recurrent ovarian cancer: an in vitro model. Gynecol Oncol. 2004 Jul; 94(1):67-73. PMID: 15262121.
    Citations: 8     Fields:    Translation:HumansCells
  162. Horowitz NS, Powell MA, Drescher CW, Smith MR, Atwood M, Mate TA, Peters WA. Adequate staging for uterine cancer can be performed through Pfannenstiel incisions. Gynecol Oncol. 2003 Mar; 88(3):404-10. PMID: 12648594.
    Citations:    Fields:    Translation:Humans
  163. Wright JD, Horowitz, NS. Gynecologic Oncology. Washington University Hematology and Oncology Consult Manual. Editors: Chanter M, Pillot G, Lin T. 2003; 197-203.
  164. Horowitz N, et al. Survival GYN/ONC. Washington University Obstetrics and Gynecology Survival Guide. Editors: Wright JD, Wyatt S, Lin T. 2003; 293-349.
  165. Cohn DE, Horowitz NS, Mutch DG, Kim SM, Manolitsas T, Fowler JM. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol Oncol. 2002 Dec; 87(3):243-6. PMID: 12468320.
    Citations: 10     Fields:    Translation:Humans
  166. Wright JD, Powell MA, Horowitz NS, Huettner PC, White F, Herzog TJ. Placental site trophoblastic tumor presenting with a pneumothorax during pregnancy. Obstet Gynecol. 2002 Nov; 100(5 Pt 2):1141-4. PMID: 12423837.
    Citations: 3     Fields:    Translation:Humans
  167. Wright JD, Horowitz NS, Rader JS. Primary peritoneal carcinoma presenting as adenocarcinoma on a Pap smear. A case report. J Reprod Med. 2002 Nov; 47(11):933-5. PMID: 12497684.
    Citations:    Fields:    Translation:Humans
  168. Horowitz NS, Cohn DE, Herzog TJ, Mutch DG, Rader JS, Bhalla S, Gibb RK. The significance of pneumatosis intestinalis or bowel perforation in patients with gynecologic malignancies. Gynecol Oncol. 2002 Jul; 86(1):79-84. PMID: 12079304.
    Citations: 5     Fields:    Translation:Humans
  169. Horowitz N, Pinto K, Mutch DG, Herzog TJ, Rader JS, Gibb R, Bocker-Edmonston T, and Goodfellow PJ. Microsatellite instability, hMLH1 methylation, and loss of mismatch repair in endometrial carcinoma and atypical hyperplasia. Gynecologic Oncology. 2002; 86(1):62-68.
  170. Horowitz N, Pinto K, Mutch DG, Herzog TJ, Rader JS, Gibb R, Bocker-Edmonston T, Goodfellow PJ. Microsatellite instability, MLH1 promoter methylation, and loss of mismatch repair in endometrial cancer and concomitant atypical hyperplasia. Gynecol Oncol. 2002 Jul; 86(1):62-8. PMID: 12079302.
    Citations: 7     Fields:    Translation:HumansCells
  171. Horowitz NS, Gibb RK, Menegakis NE, Mutch DG, Rader JS, Herzog TJ. Utility and cost-effectiveness of preoperative autologous blood donation in gynecologic and gynecologic oncology patients. Obstet Gynecol. 2002 May; 99(5 Pt 1):771-6. PMID: 11978286.
    Citations: 1     Fields:    Translation:Humans
  172. Horowitz NS, Peters WA, Smith MR, Drescher CW, Atwood M, Mate TP. Adjuvant high dose rate vaginal brachytherapy as treatment of stage I and II endometrial carcinoma. Obstet Gynecol. 2002 Feb; 99(2):235-40. PMID: 11814503.
    Citations: 13     Fields:    Translation:Humans
  173. Horowitz NS, Rader JS. Role of the ultrasonic surgical aspirator in gynecology. Obstet Gynecol Clin North Am. 2001 Dec; 28(4):775-90. PMID: 11766151.
    Citations:    Fields:    Translation:Humans
  174. Dotan I, Yeshurun D, Hallak A, Horowitz N, Tiomny E, Reif S, Halpern Z, Rachmilewitz D. [Treatment of Crohn's disease with anti TNF alpha antibodies--the experience in the Tel Aviv Medical Center]. Harefuah. 2001 Apr; 140(4):289-93, 368. PMID: 11303390.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  175. Horowitz NS, Tamimi HK, Goff BA, Koh WJ, Schmidt RA, Greer BE, Paley PJ. Pretreatment scalene node biopsy in gynecologic malignancy: prudent or passé? Gynecol Oncol. 1999 Nov; 75(2):238-41. PMID: 10525379.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  176. Horowitz N, Cohn DE, Luna JA, Winter TJ, Tamimi HK. . Intraoperative ultrasound in the management of ovarian germ cell tumors. Journal Gynecol Tech. 1999; 5:91-94.
  177. Hooley R, Lee C, Tocino I, Horowitz N, Carter D. Calcifications in axillary lymph nodes caused by fat necrosis. AJR Am J Roentgenol. 1996 Sep; 167(3):627-8. PMID: 8751666.
    Citations: 3     Fields:    Translation:Humans
  178. Horowitz NS, Staats HF, Palker TJ. Effect of bismuth salts on systemic and mucosal immune responses to orally administered cholera toxin. Immunopharmacology. 1995 Nov; 31(1):31-41. PMID: 8655289.
    Citations:    Fields:    Translation:AnimalsPHPublic Health
  179. Smith HG, Horowitz N, Silverman NA, Henson DE, Chretien PB. Humoral immunity to herpes simplex viral-induced antigens in smokers. Cancer. 1976 Sep; 38(3):1155-62. PMID: 182350.
    Citations:    Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Horowitz's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (445)
Explore
_
Co-Authors (112)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.